News|Podcasts|May 19, 2019

Podcast: This Week in Managed Care—Drug Makers Accused of Price Fixing and Other Health News

Every week, The American Journal of Managed Care® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

Every week, The American Journal of Managed Care^® recaps the top managed care news of the week, and you can now listen to it on our podcast, Managed Care Cast.

This week, the top managed care news included 44 states suing drug makers for price fixing; Gilead pledging to donate pre-exposure prophylaxis for up to 200,000 people for up to 11 years; Philadelphia soda tax reduced consumption of sugary drinks.

You may need to log in to the website to access this podcast.

Listen above or through one of these podcast services:

What We're Reading: Drug Makers Accused of Price-Fixing; Washington State Public Option Insurance; Vaccine Exemptions Stall

Reactions Are Mixed as Gilead Announces PrEP Donations, Early Launch of Generic

Sales of Sweetened Drinks Fell 38% After Philadelphia Beverage Tax

Chemotherapy Demand Will Rise Significantly by 2040, and Workforce Will Need to Expand With It

ISPOR 2019 (Coverage Starting May 20)

American Psychiatric Association 2019 Annual Meeting (Coverage Starting May 19)

Newsletter Sign-up

Read more about the stories in this podcast:

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related to this article

Lung cancer image. | Image credit: @mi_viri _AdobeStock.com

September 22nd, 2026

Lung Cancer Progress Drives Down US Cancer Death Rates

CDC data show cancer deaths declining as lung cancer treatment and detection advance, with new KRAS-targeted therapies showing early promise.

September 22nd, 2026

Semaglutide Adherence Falls Once Out-of-Pocket Costs Top $75 a Month

Nonadherence to semaglutide for obesity worsened once out-of-pocket costs passed roughly $75 per 30-day supply among commercially insured adults.

Robert Z. Orlowski, MD, PhD | Image: MD Anderson Cancer Center

September 22nd, 2026

Panel Confronts the Practical Barriers to Bringing Bispecifics Into Community Myeloma Care

At a Stakeholder Interchange convened by The American Journal of Managed Care® in Houston, Texas, oncologists and pharmacists from academic and community practices debated how teclistamab- and talquetamab-based regimens stack up against CAR T-cell therapy in second-line multiple myeloma, and what it will take—staffing, caregiver support, hospital partnerships, and payer buy-in—to move step-up dosing out of the hospital and into the clinic.

Person holding a piggy bank. | Image credit: @fizkes_AdobeStock.jpeg

September 22nd, 2026

All 50 States Apply for CMS's GENEROUS Model, With $64.3B in Savings Projected

All 50 states have applied for CMS's GENEROUS Model, a Medicaid drug pricing program expected to save $64.3 billion over the next decade.

FDA approval- jittawit21-stock.adobe.com.jpeg

September 22nd, 2026

FDA Adds HYPERION Data to Sotatercept-csrk Label for Early PAH

HYPERION trial data shows a 76% reduction in clinical worsening events among adults recently diagnosed with PAH.

September 22nd, 2026

Contributor: Better Diabetes Management Starts With Sustaining the Behaviors That Drive Outcomes

Diabetes care improves when support adapts to real-life changes, removing barriers and sustaining daily habits beyond reminders, education, and one-time interventions.